Streptococcus salivarius K12 and Reduced Nasopharyngeal Moraxella Abundance

• Impact of Streptococcus salivarius K12 on Nasopharyngeal and Saliva Microbiome: A Randomized Controlled Trial.

  • 2020-12-08
  • RCT · n = 121
  • The Pediatric infectious disease journal 40(5)
  • • Suvi Sarlin
    • Mysore V Tejesvi
    • Jenni Turunen
    • Petri Vänni
    • Tytti Pokka
    • Marjo Renko
    • Terhi Tapiainen

  • PubMed: 33298762
  • DOI: 10.1097/inf.0000000000003016

  10 Insights on

  • Reduced Nasopharyngeal Moraxella Abundance

  • High evidence
  • Large Human Trial
  • Children

  When we compared each otopathogen separately, Moraxella was the only group lower in the treatment group. We could not verify the reduction of Moraxella when an alternative Human Oral Microbiome Database taxonomy database was used.

  Effect

  Neutral

  Effect size

  Small

  Significant

  No

  Dose

  not stated